Adjuvant therapy with antidepressants for the management of inflammatory bowel disease

Antonina Mikocka-Walus, Andrea Fielder, Stephanie L. Prady, Adrian J. Esterman, Simon Knowles, Jane M. Andrews

Research output: Contribution to journalArticle

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objectives 1. To assess the efficacy and safety of antidepressants for managing anxiety and depression in IBD 2. To assess the efficacy and safety of antidepressants for managing quality of life in IBD Secondary objectives 1. To assess the efficacy and safety of antidepressants for managing disease activity in IBD

Original languageEnglish (US)
Article numberCD012680
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number7
DOIs
StatePublished - Jul 6 2017

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Adjuvant therapy with antidepressants for the management of inflammatory bowel disease'. Together they form a unique fingerprint.

  • Cite this

    Mikocka-Walus, A., Fielder, A., Prady, S. L., Esterman, A. J., Knowles, S., & Andrews, J. M. (2017). Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database of Systematic Reviews, 2017(7), [CD012680]. https://doi.org/10.1002/14651858.CD012680